This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Information about Osteoid Osteoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Most recent studies have shown that Osteoid Osteoma shares some biological mechanisms with benign-neoplasm, bone-cysts, bone-neoplasms, chondroblastoma, chondroma, chondrosarcoma, fibroma, giant-cell-tumors, malignant-paraganglionic-neoplasm, neoplasm-metastasis, neoplasms, osteoblastoma, osteoma, osteomyelitis, osteosarcoma, pain, sarcoma, sclerosis, spinal-neoplasms.
Among the many pathways, these few ones have gauged particular interests from scientists studying Osteoid Osteoma, and have been seen in publications frequently: Bone Remodeling, Bone Resorption, Cell Adhesion, Coagulation, Endochondral Ossification, Enucleation, Excretion, Immune Response, Innervation, Localization, Muscle Atrophy, Muscle Contraction, Ossification, Osteoblast Proliferation, Pathogenesis, Reflex, Regeneration, Secretion, Wound Healing
Quite a number of genes have been found to play important roles in Osteoid Osteoma, such as BGLAP, C2, C5, CAT, CERS2, CRAT, DBT, GLYAT, HNRNPC, MID1, NT5E, PTGS2, REG3A, RPL3, RPL5. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.